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University of Vermont, College of Engineering and Mathematical Sciences, Burlington, VermontABSTRACT The generation of proteolyzed prothrombin species by preassembled prothrombinase in phospholipid-coated
glass capillaries was studied at physiologic shear rates (100–1000 s1). The concentration of active thrombin species
(a-thrombin and meizothrombin) reaches a steady state, which varies inversely with shear rate. When corrected for shear
rate, steady-state levels of active thrombin species exhibit no variation and a Michaelis-Menten analysis reveals that chemistry
of this reaction is invariant between open and closed systems; collectively, these data imply that variations with shear rate arise
from dilutional effects. Significantly, the major products observed include nonreactive species arising from the loss of prothrom-
bin’s phospholipid binding domain (des F1 species). A numerical model developed to investigate the spatial and temporal distri-
bution of active thrombin species within the capillary reasonably approximates the observed output of total thrombin species at
different shears; it also predicts concentrations of active thrombin species in the wall region sufficient to account for observed
levels of des FI species. The predominant feedback formation of nonreactive species and high levels of the primarily anticoag-
ulant intermediate meizothrombin (~40% of total active thrombin species) may provide a mechanism to prevent thrombus prop-
agation downstream of a site of thrombosis or hemorrhage.INTRODUCTIONMost of our knowledge of blood coagulation comes from
experiments in closed systems. While this approach has
allowed for great understanding of this important biological
process (1), these studies do not reflect how the dynamics of
the system may be altered in the vasculature. Several studies
have looked at the activation of coagulation zymogens in
purified protein systems under flow (2–9); additional studies
have looked at the effect of flow on coagulation from the
standpoint of modeling (10,11), as well as in whole blood
and plasma-based flow experiments (11,12).
In this article, we seek to build upon previous studies
investigating the activation of the zymogen prothrombin
(factor (F)II) to the enzyme a-thrombin (aIIa) under condi-
tions of flow (6,8,9). aIIa is a key enzyme in both pro- and
anticoagulant pathways. The major source of aIIa is through
the activation of FII by the prothrombinase complex, which
is composed of factors Va and Xa (FVa-FXa), assembled on
an appropriate membrane surface in the presence of calcium
(Ca2þ). The kinetics of this process has been extensively
studied in closed system experiments (1,13,14). The activa-
tion of bovine FII by membrane anchored prothrombinase is
preceded by FII binding to the phospholipid membrane
followed by an initial cleavage at Arg323 to produce meizo-
thrombin (mIIa) and a second cleavage at Arg274 resulting in
the generation of aIIa (15,16). A feedback cleavage at
Arg156 of FII and mIIa by aIIa and/or mIIa results in the
release of the phospholipid-binding domain, fragment 1
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0006-3495/11/02/0765/9 $2.00mIIa(des F1) (17,18). A diagram of these cleavages is illus-
trated in Fig. S1 in the Supporting Material.
Flow contributes to a diverse number of roles in the coag-
ulation process (19,20). In addition to its impact on cells
(19), flow influences the molecular architecture of some
plasma proteins such as von Willebrand Factor and
ADAMTS-13 (21), provides a continuous source of sub-
strates for the localized coagulation catalysts which form
in response to vasculature damage, and removes products
from the site of injury. For studies of flow within the vascu-
lature, the wall shear rate has become an accepted means of
describing localized flow conditions. Shear rates within the
vasculature system cover a dynamic range from ~50 s1 in
the inferior vena cava to 1900 s1 in the arterioles (19).
The effect of flow on a localized membrane-bound cata-
lytic system, such as prothrombinase, is multifold. As the
shear rate is increased, the rate at which new substrates
are brought into the catalytically active region increases;
however, the substrate residence time within that region is
diminished. This creates a competition between dilutional
and diffusional effects (20,22,23). In the latter instance,
reaction dynamics are driven by substrate diffusion between
the catalytically active wall region and the bulk solvent.
Conditions favoring such dynamics include low flow rate,
low substrate concentration, large tube dimensions, and
low substrate diffusion constants (23).
Previous reports have investigated the influence of shear
rate on product formation by prothrombinase, but in these
studies the processes of prothrombinase complex formation
and catalysis were not segregated (6,8,9). In this study, we
examine the activation of bovine FII to aIIa and mIIa by im-
mobilized preformed bovine prothrombinase complex atdoi: 10.1016/j.bpj.2010.12.3720
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roughly to the dynamic range of shear rates found in the
arterial and much of the venous system. Additionally we
investigate the enzyme kinetics of the prothrombinase
complex under flow at a shear rate of 250 s1, which is
representative of typical venous shear rates (19). The poorly
reactive side products, mIIa(des F1) and Pre1, are quanti-
tated and related to the distribution of active thrombin
species (aIIaþmIIa) in the capillary.
Having an understanding of the complex contributions of
flow to the coagulation process will permit extrapolation
from test-tube experiments to more physiologically relevant
open systems. This will permit an understanding of the
dynamics of occlusive clot formation, and the delivery and
removal of pharmaceuticals.MATERIALS AND METHODS
Materials
Synthetic phospholipid vesicles (PCPS) were prepared from 75% dioleoyl
phosphatidylcholine (PC) and 25% dioleoyl phosphatidylserine (PS) from
Avanti Polar Lipids (Alabaster, AL) as described previously (24). Dansylargi-
nine n-(3-ethyl-1,5-pentanediyl)amide (DAPA) (25) andRussel ViperVenom
Xa Activator were gifts from Haematologic Technologies (Essex Junction,
VT). Ecarinwas purchased fromCenterchem (Norwalk,CT). Thefluorogenic
FXa substrate SN-7 (26) and D-Phe-Pro-ArgCH2Cl were prepared in house.
SpectozymeTH was purchased from American Diagnostica (Stamford,
CT). Heparin was purchased from Sigma-Aldrich (St. Louis, MO).
A polyclonal burro anti-human Pre1 antibody was obtained from the
Antibody Core at the University of Vermont (Colchester, VT). Bovine
FII, FVa, and FXa were utilized because they present a simpler system
from that of their human analog and were isolated from bovine plasma
(27,28) or obtained as gifts from Haematologic Technologies. Bovine FX
was activated to bovine FXa with Russel Viper VenomXa Activator. Bovine
FVa was isolated as described previously, dialyzed, and stored in HBS
(20 mM HEPES, 150 mM NaCl, pH ¼ 7.4) at 80C (29). Bovine mIIa
was generated from FII using Ecarin in the presence of DAPA. Pre1 was
prepared from a digestion of FII with aIIa (30) and purified using a BioCad
700E (Applied Biosystems, Foster City, CA) equipped with a HS20A
column. Human antithrombin (AT) was isolated in-house (31).Preparation of flow chamber
Borosilicate glass capillaries (2 mm  0.2 mm  5 cm) (Vitrocom, Moun-
tain Lakes, NJ) were plasma-cleaned on the high setting for 30 min in
a PDC-3XG plasma cleaner (Harrick, Pleasantville, NY) with atmospheric
gas. Glass capillaries were filled with a solution of 100 mM PCPS vesicles
in HBS2 (20 mMHEPES, 150 mMNaCl, 2 mMCaCl2, pH¼ 7.4) and incu-
bated at 4C for 1 h to assemble a supported phospholipid bilayer (32,33).
The capillaries were rinsed three times with HBS2 via capillary action and
stored overnight under HBS2. Before each flow experiment, bovine pro-
thrombinase was assembled in the PCPS-coated capillary at a nominal level
of 4 fmoles by filling the 20 mL capillary with a solution containing 20 nM
FVa and 0.2 nM FXa in HBSP2 (20 mM HEPES, 150 mM NaCl, 2 mM
CaCl2, 0.1% polyethylene glycol, pH ¼ 7.4), incubating for 1 h at 37C.Flow experiment procedure
Temperature (37 5 3C) was controlled over the course of these experi-
ments by means of a thermostat and heat lamp in an insulated PlexiglasBiophysical Journal 100(3) 765–773box. Flow rates were controlled using a Model 22 syringe pump (Harvard
Apparatus, Holliston, MA). A prothrombinase-coated glass capillary was
attached to the pump using 23 cm of Silastic tubing (ID ¼ 1.65 mm)
(Dow Corning, Midland, MI) and a 20 gauge blunt tip needle. At the
outflow side of the capillary 3 cm of tubing was added to ease collection.
Approximately 100 mL of HBSP2 was flowed through the capillary at
a shear rate of 100 s1 (0.085 mL/min) before each experiment.
A reaction mixture containing FII or Pre1 in HBSP2 was flowed through
the capillary at shear rates ranging from 100 to 1000 s1 and collected drop-
wise (~23 mL/drop) into a 96-well plate with each well containing 155 mL
quench buffer (20 mM HEPES, 150 mM NaCl, 20 mM EDTA, 0.1% poly-
ethylene glycol, pH¼ 7.4) for analysis of aIIaþmIIa activity. The drop size
was found to be consistent and independent of shear by gravitometric anal-
ysis, allowing the number of drops to be used as an internal clock. For anal-
ysis by quantitative Western blotting, two drops of effluent were collected
into a final concentration of ~3.5 mM D-Phe-Pro-ArgCH2Cl to stop further
reactions.
Intrinsic fluorescence of the collected outflow was monitored to establish
the time of inflowing fluid entry into the capillary using a Synergy 4 fluo-
rescence plate reader (BioTek Instruments, Winooski, VT) at 37C with an
excitation wavelength (lex) of 280 nm and an emission wavelength (lem) of
320 nm. SpectrozymeTH (200 mM) was used in a kinetic assay to determine
the total concentration of aIIaþmIIa on a SpectraMax 340 absorbance plate
reader (Molecular Devices, Sunnyvale, CA). The ratio of aIIa/mIIa in the
effluent at shear rates of 250 and 500 s1 was determined using the method
of Coˆte´ et al. (34), which takes advantage of the differential reactivity of
aIIa and mIIa toward the AT-heparin complex. Detailed descriptions of
these procedures are given in the Supporting Material.
Capillary prothrombinase content was determined by removing the
limiting FXa from the capillary by chelation with quench buffer (200 mL)
and measuring its concentration in a fluorogenic assay (lex ¼ 350 nm,
lem ¼ 470 nm, cutoff filter ¼ 450 nm at 37C) with SN-7 (35.7 mM) in
the presence of hirudin (237 nM) over 5 min on a Fluoromax-2 fluorometer
(Jobin Yvon-Spex, Edison, NJ).
Steady-state concentrations of aIIaþmIIa were used in further analysis.
The relative concentrations aIIa and mIIa cannot be distinguished as their
reactivities towardSpectrozymeTHdiffer by ~10%,which is not distinguish-
able by the analytical techniques implemented (35,36). QuantitativeWestern
blotting was used to estimate the extent of aIIaþmIIa diffusion from the rate
of des F1 species generation as described in the Supporting Material.Closed system kinetic analyses
The rates of FII activation by prothrombinase and FII conversion to Pre1 by
aIIaþmIIa in closed systems were determined as described in the Support-
ing Material.THEORY
A numerical model for the activation of FII to aIIa based on
a one-step mechanism is used to gain insights into the
spatial distribution of aIIaþmIIa that cannot be measured
experimentally and to synthesize our findings. This model
does not include the feedback cleavage at Arg156 (for justi-
fication, see Supporting Material) and solves for the trans-
port of aIIaþmIIa in a fully developed, two-dimensional
channel flow. The dimensions of the channel match the
height (H) and length (L) of the experimental capillary.
The flow and species transport is characterized by the Rey-
nolds number,
Reb ¼ Ubh=n;
Prothrombin Activation under Flow 767and, for each species (here denoted by i), the Peclet number
Pei ¼ Ubh=Di;
and the Schmidt number
Sci ¼ n=Di;
where Ub is the bulk velocity, n the solvent viscosity, h is the
half-height of the capillary, and Di the diffusivity of species
i. The Reynolds and Peclet numbers are the ratio of inertia to
viscous forces in the solvent and the inertia to species diffu-
sivity, respectively. Lastly, the reaction rate is characterized
by the Damko¨hler number
Dai ¼ kcath2=Di;
the ratio of the chemical reaction rate to diffusion rate.
These parameters are listed in Table 1.
The low Reynolds and the large Peclet numbers indicate
that the flow is laminar and that the transport of species is
dominated by flow convection. The relatively large Dam-
ko¨hler number also indicates that the activation of FII under
these flow conditions is dominated by the reaction rate. Due
to the low Reynolds number of the flow and a smooth junc-
tion between the tube connecting to the capillary to the
pump, it is assumed that the flow in the capillary is fully
developed and the effect of side walls is negligible. The
capillary is therefore modeled in a two-dimensional domain
where the velocity profile is defined as the Poiseuille
velocity profile,
uðzÞ ¼ Sz

1 z
H

; (1)
where z is the vertical coordinate and S the wall shear of the
flow. FII activation is modeled by a one-step reaction in
which aIIa and mIIa are treated as equivalently active
species,
FII!prothrombinaseðaIIaþmIIaÞ; (2)
which occurs within a thin shell at the capillary walls under
Michaelis-Menten kinetics defined by empirical constants
obtained under flow conditions at 250 s1 in this study.
The model differs from Neeves et al. (2), where the reac-
tion is considered to take place on the surface of theTABLE 1 Relevant constants and fluid dynamics terms at
37C
Parameter Value
Reynolds number 1–10
Peclet number 104–105
Damko¨hler number 8000
DFII* 9.35  1011 m2 s1
DaIIa
y 13.42  1011 m2 s1
*From Lim et al. (50).
yFrom Harmison et al. (51).channel. Although the two methods are equivalent, our
motivation for the shell model is to test the proposition
(37) that FII activation may be modeled as occurring in
a 8.5-nm shell volume around vesicle outer membranes
in a static system. The reaction is therefore present in the
transport equation of species, 4, as source term P4 (4 ¼
FII or aIIaþmIIa),
uðzÞv4
vx
¼ Df

v24
vx2
þ v
24
vz2

þ
Y
4
; (3)
where x is the longitudinal direction, and D4 is the diffusivity
coefficient of 4. The inlet concentration of FII (1.4 mM) is
constant. The source term is zero everywhere except for
z % D or (Hz) % D and x R 0, with D ¼ 8.5 nm, where
PII ¼ V and PaIIaþmIIa ¼ þV, where V is the rate of the
reaction. Equation 3 is solved using an in-house computa-
tional fluid dynamics code, described in the SupportingMate-
rial along with grid convergence studies. The computational
domain is defined between 1 cm% x % 5 cm and 0 % z
% 0.2 mm. Simulations are run to steady-state convergence,
inasmuch as this study is only interested in the steady-state
production of aIIaþmIIa. The concentration of product at
any location x is calculated from its mass flux,
½aIIaþ mIIax ¼
6
SH2
Z H
0
½aIIaþ mIIaðx; zÞ uðzÞ dz; (4)
where u(z) is the flow velocity defined in Eq. 2 and SH2/6 is
the flux of fluid per unit width in the capillary. Equation 4 is
used with x ¼ L for the simulated concentration of product
at the end of the capillary.
The dilutional effect on FII activation is easily predicted
by considering that Eq. 3 is similar to the well-known Graetz
problem (38), which yields a self-similar solution in the
form
½aIIaþ mIIa ¼ ½aIIaþ mIIawðxÞ , f ðhÞ; (5)
where [aIIaþmIIa]w(x) is thewall concentration at a distance
x from the onset of activation. The vertical coordinate is
normalized by the concentration boundary layer thickness,
h ¼ z
dFIIaðxÞ: (6)
The concentration boundary layer thickness is typically
defined as the local altitude at which the concentration is,
in the case of aIIaþmIIa, a fixed fraction of a reference
concentration. Here, the edge of the concentration boundary
layer may actually be defined by the critical threshold of
aIIaþmIIa (2 nM) to cause clot formation (39). Considering
that the transport mechanisms of aIIa and mIIa are only
a function of shear and diffusion (Eq. 3), the growth of the
concentration boundary layer may be estimated from
dimensional considerations with the diffusion coefficients
(D) listed in Table 1. The DaIIa was used to model both
aIIa and mIIa diffusion, asBiophysical Journal 100(3) 765–773
FIGURE 1 Steady-state concentrations of active thrombin species across
physiologic shear rates. Steady-state levels of aIIaþmIIa generation at
shear rates between 100 and 1000 s1 are shown as the average and the stan-
dard deviation of repeated measurements as denoted by n. Note the decrease
in the absolute concentration of active thrombin species with increasing
shear rate. When normalized to account for shear rate and prothrombinase
density (inset), the generation of active thrombin species is consistent
across the range of shear rates. Empirical results are compared to our
computational model (solid lines).
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
DaIIax
S
1=2
: (7)
Using conservation of concentration over a control
volume between x and xþDx, the argument can be made
(see the Supporting Material) that the wall concentration
of aIIa and mIIa increases linearly with the boundary layer
concentration,
½FIIaþ mIIawðxÞzCdFIIaþmIIaðxÞ; (8)
where C is a constant of units M m1. Combining Eqs. 5–8
into Eq. 4, the concentration of aIIa þ mIIa collected at any
location x, ½aIIaþ mIIax, may be estimated as
½aIIaþ mIIaxz12C
DaIIax
SH2
Z1
0
h

1 daIIaþmIIaðxÞ
H
h

f ðhÞdh:
(9)
When
dFIIa þ mIIaðxÞ  H;
the integral in Eq. 9 reduces toZ 1
0
hf ðhÞdh;
which is independent of shear, and the product is therefore
proportional to
½aIIaþ mIIaxfx=S: (10)
This assumption proves to be valid for x ¼ L even at the
lowest shear, for which the product boundary layer merges
toward the end of the capillary. A boundary layer thickness
based on 2 nM of aIIaþmIIa is, from the perspective of
Eq. 10, only valid in the immediate downstream vicinity of
the onset of FII activation. In vivo prothrombinase activity
is confined to relatively small regions, thus our initial defini-
tion of the concentration boundary layer thickness is relevant.
Our empirical model, however, requires a modification to
include the integrated effect of prothrombinase over a rela-
tively larger region—an effective boundary layer thickness
that accounts for the competition between flow and
aIIaþmIIa diffusion. A more adequate approach to model
our empirical system is to consider a normalization of the
distance from the wall by the left-hand side of Eq. 7, i.e.,
h ¼ z=dDðxÞ;
where
dDðxÞ ¼ ðDaIIax=SÞ1=3:
This boundary layer definition, similar to that used by
Neeves et al. (2), yields dD(L)/H% 0.4 for the lowest shear.
The effective boundary layers developing over the top and
lower wall do not merged at the end of the capillary atBiophysical Journal 100(3) 765–773low shear. Moreover, dD(L)/H << 1 is verified over most
of the capillary length (see the Supporting Material), which
results in the linear dependence of aIIaþmIIa in x.RESULTS
Determination of total prothrombinase
in capillaries
Twenty-seven capillaries used in this studywere analyzed for
their respective FXa contents andwere determined to contain
3.95 1.9 fmoles (standard deviation). Despite the large stan-
dard deviation, this number is in agreement with the theoret-
ical 4 fmoles of FXa introduced to the capillary, suggesting
the prothrombinase is not being eluted from the capillary.
Variations in FXa levels did not correlate with variations in
amounts of aIIaþmIIa generated in a given capillary.Active thrombin species generation under flow
Typical FII (1.4 mM) activation curves are shown in Fig. S5
across the range of shear rates in this study (100–1000 s1).
The absolute steady-state levels of aIIaþmIIa show
a decrease with increasing shear rate (Fig. 1). When
aIIaþmIIa concentrations are adjusted for the effective
volumetric dilution due to increasing shear rate, the normal-
ized aIIaþmIIa concentrations at the steady state appear
nearly equivalent (Fig. 1, inset). Deviations in FII activation
observed at higher shear rates (750 and 1000 s1) within the
empirical data are not statistically significant from lower
shear rates due to detection limits of the assay and shear-
induced dilutional effects. To overcome these limitations,
FIGURE 2 Computational models of FII activa-
tion of under flow. (A) Linear dependence of total
aIIaþmIIa concentration on the streamwise
distance from the entrance of the capillary, x, as
a function of shear rate (100–1000 s1) as indi-
cated in the legend. (B) The concentration of
aIIaþmIIa as a function of x in the wall region
([aFIIaþmIIa]wall), defined at a height of 8.5 nM.
(C) aIIaþmIIa concentration profiles in the
vertical direction at the capillary exit as a function
of shear rate. (D) aIIaþmIIa flux profiles in the
vertical direction at the capillary exit as a function
of shear rate. For panels C and D, only the lower
half of the capillary is plotted.
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nase. These also exhibited no statistically significant change
in steady-state aIIaþmIIa levels when shear rate corrected
(data not shown). Fig. 1 also displays the good agreement
between the computational model and empirical measure-
ments and validates the 1/S behavior described in Eq. 7.
Fig. 2 presents computational analyses detailing the shear
dependence of the distribution of aIIaþmIIa as a function of
distance along the capillary (Fig. 2, A and B) and from the
catalytically active wall (Fig. 2, C and D). Consistent with
the empirical data, the computational model shows an
inverse dependence between shear and aIIaþmIIa levels
across the capillary (Fig. 2 A), as well as in the shell region,
defined as 8.5 nM above the capillary wall (Fig. 2 B).
However, aIIaþmIIa levels in the wall region are less sensi-
tive to shear, showing only a 2.5-fold variation versus the
10-fold range over the total cross section. The distribution
of aIIaþmIIa at the exit of the capillary is illustrated
spatially (Fig. 2 C) and with respect to product flux
(Fig. 2 D). Significant diffusion away from the wall region
is notable at lower shear rates, indicating that transport of
products away from the wall will be most extensive with
reduced flow.FIGURE 3 Kinetic analysis of FII activation by preassembled prothrom-
binase under flow. The rate of FII activation to active thrombin species is
shown here as a function of prothrombin concentration in the inflowing
fluid at a shear rate of 250 s1. The open circles (B) represent measured
values and error bars show the standard deviation of a least two measure-
ments. (Dotted line) Fit of the data to the Michaelis-Menten equation.
From this fit, kinetic constants were obtained which are in close agreement
with those obtained in closed system experiments shown in the solid
circles ().Michaelis-Menten analysis of FII activation under
flow
The steady-state levels of aIIaþmIIa as a function of FII
concentration were studied at a shear rate of 250 s1
(Fig. 3). At the steady-state plateau, the rate of reaction
(Vrxn) is equivalent to the initial rate in a closed system
because of the constant influx of substrate. Vrxn was deter-
mined by taking the absolute aIIaþmIIa concentration at
the steady state and dividing it by the average time it takesone capillary volume to transit the capillary (5.6 s at a shear
rate of 250 s1). The concentration of enzyme was
assumed to be 200 pM (the nominal 4 fmoles of limiting
FXa in the 20 mL capillary). From these measurements,
a Michaelis-Menten analysis was conducted (Fig. 3).
Under flow conditions at 250 s1 and 37C, the kinetic
constants were determined to be Km ¼ 0.16 5 0.1 mM
and kcat ¼ 275 4 s1. A closed system Michaelis-Menten
analysis of this reaction using the same reagents at 37C
showed similar kinetic constants compared to the flow
system (Km ¼ 0.24 5 0.1 mM and kcat ¼ 25 5 3 s1)
and in close agreement with literature values (40).Biophysical Journal 100(3) 765–773
FIGURE 4 Identification of active thrombin species produced under
flow. Inflowing fluid containing 1.4 mM FII was flowed over phospho-
lipid-coated capillaries containing a nominal 4 fmoles assembled prothrom-
binase and collected into 500 nM DAPA to a final volume of 2 mL. AT
(1 mM) was added (t ¼ 0) and incubated at 25C while monitoring the fluo-
rescence signal (lex¼ 280 nm, lem¼ 565 nm). Heparin (6 units mL1) was
added (arrow) after 100 s and the fluorescence signal was recorded for an
additional 300 s. The percent decline in fluorescence intensity relative to
that of the collected effluent in the presence of DAPA and AT corresponds
to the relative ratio of mIIa to aIIa. The ratios of mIIa/aIIa at a shear rate of
250 s1 () and 500 s1 (:) are shown. Curves indicating control experi-
ments with 100% mIIa, 100% FIIa, and a 50:50 mixture are also shown as
indicated.
FIGURE 5 Feedback production of des F1 species under flow. (A) Repre-
sentative nonreduced Western blot of reaction products formed when
1.4 mM FII is flowed through a phospholipid-coated capillary containing
a nominal 4 fmoles prothrombinase at a shear rate of 250 s1. Effluent
(two drops) was collected into D-Phe-Pro-ArgCH2Cl (~32 mM) and
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
gel electrophoresis using a 4–12% gradient gel before transfer to a nitrocel-
lulose membrane. The membrane was probed with a burro anti-human pre1
polyclonal antibody. Species are labeled on the left and the time course
under flow is indicated above each lane. The intense FII band indicates
that only a small fraction of the bulk FII in the inflowing fluid is being
consumed (<5%) under flow, in agreement with thrombin activity assays
(Figs. 1 and 2). The mIIa formation accounts for ~0.5% of the initial FII
concentration. (B) Typical thrombin generation profile at a shear rate of
250 s1 with an initial FII concentration of 1.4 mM in the inflowing fluid
in the solid circles (). The solid triangles (:) show relative aIIa generation
from the nonreducedWestern blot in panel Awhere aIIa generation at 204 s
was taken to be 100%.
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To distinguish the amount of the catalytically active inter-
mediate mIIa present in the effluent, we utilized the differ-
ential reactivities of mIIa and aIIa toward AT and heparin.
It has been reported previously that while aIIa and mIIa
are both inhibited by AT, the presence of heparin dramati-
cally increases AT inhibition of aIIa but not of mIIa or
mIIa(des F1). This reaction can be monitored by displace-
ment of DAPA (34) from the enzyme-DAPA complex.
Fig. 4 illustrates representative results of this assay at 250
and 500 s1. The ratio of aIIa/mIIa was 3:2 independent
of shear at these flow rates. See Table 2 for information
on the relative activity of meizothrombin.Generation of des F1 species under flow
and estimates of active thrombin species
concentrations
aIIa and mIIa cleave FII and mIIa at Arg156, removing the
membrane binding F1 domain from and resulting in Pre1
and mIIa(des F1), respectively. This cleavage reduces the
effective concentration of FII because Pre1 and mIIa(desTABLE 2 Relative activity of meizothrombin
Substrate Relative activity (% aIIa)*
Fibrinogen 7%
Platelets 2%
Thrombomodulin þ Protein C 93%
Thrombomodulin þ TAFIy 10%
*From Coˆte´ et al. (34).
yThrombin activatable fibrinolysis inhibitor.
Biophysical Journal 100(3) 765–773F1) have lost their membrane binding domains. TheWestern
blot of nonreduced samples obtained at a shear rate of
250 s1 in Fig. 5 A shows modest but significant amounts
of des F1 species (Pre1 and mIIa(des F1)) being generated.
The concentration of des F1 products permits estimation of
the localized aIIaþmIIa, which is ~2.9 times the concentra-
tion of aIIa observed in the collected effluent between 49
and 204 s. The relative distribution of des F1 species and
aIIa are fairly consistent across this time-frame, with the
average of two experiments showing this ratio to be
2.3 5 0.9. The time-course of aIIa generation estimated
from densitometry in this analysis is consistent with activity
measurements of aIIaþmIIa in the effluent (Fig. 5 B). Over-
all, ~96% of the FII is not proteolyzed, with ~3% des F1
species (Pre1 R 2.5%), 1% aIIa, and 0.5% mIIa and mIIa
(des F1) being generated under steady-state conditions.
The computational model provides a spatial and temporal
justification for the high levels of des F1 species observed.
The second-order rate constant for aIIa proteolysis at
Arg156 resulting in Pre1 formation in the presence of
2 mM Ca2þ and 20 mM PCPS was determined under closed
Prothrombin Activation under Flow 771system conditions to be 7000 M1 s1—comparable with
previously reported literature values (17,18). Given the ratio
of aIIa to Pre1 determined by Western blot analysis, the
concentrations of aIIaþmIIa in the wall region must be at
least an order-of-magnitude higher than those measured in
the bulk effluent. This observation is in agreement with
our computational model (Fig. 2 B), which predicts that
the concentration of aIIaþmIIa in the wall region is
relatively undiluted by diffusional processes and at a level
sufficient to catalyze the formation of these prothrombin
cleavage products.Pre1 activation under flow
With Pre1 as the initial substrate over a capillary, little
generation of aIIaþmIIa was observed as compared to FII
at the same concentration and shear rate (Fig. 6). Given
the low concentrations of aIIaþmIIa generated in the Pre1
system, we were unable to quantify the types of species
being formed. These results indicate that in the absence of
the phospholipid binding domain there is limited activation
of Pre1 relative to FII, consistent with the conclusion that
the substrate is delivered to the enzyme by the membrane
(42).DISCUSSION
When normalized for flow dilution, aIIaþmIIa levels at
steady state are constant over the shear rates in this study.
This observation is consistent with the conclusion that
decreases in aIIaþmIIa in the outflow are a direct result
of a dilutional effect corresponding to the time that a given
volume of fluid spends in the catalytically active capillary.
From this perspective, a model can be devised in whichFIGURE 6 Activation of Pre1 under flow. Inflowing fluid containing
1.4 mM Pre1 was flowed through a phospholipid-coated capillary contain-
ing a nominal level of 4 fmoles prothrombinase and the effluent was as-
sayed for thrombin activity (). Subsequently the same capillary was
perfused with an inflowing fluid containing 1.4 mM FII at ~300 s (arrow)
and assayed for thrombin activity (B). The concentration of active thrombin
species is presented as a percentage relative to the greatest concentration of
thrombin measured.the zymogens in the flowing fluid will have less time to
diffuse to the catalytic factories on the capillary surface as
the shear rate is increased. The implication of this observa-
tion is that it is the intrinsic differences in shear rates
throughout the vasculature that are, at least partially, respon-
sible for the regulation of coagulation. Variations in the
local aIIaþmIIa concentrations under changing flow condi-
tions (Fig. 2) most likely serve to drive different mecha-
nisms of clot formation (2,43), while the chemistry of FII
activation is independent of flow (Figs. 1 (inset) and 4).
The relatively high physiologic concentration of FII
provides an abundant source of potential substrate and
prevents depletion of substrate that can diffuse to the cata-
lytically active wall (22,23). This level of regulation ensures
that FII activation follows the same biochemistry regardless
of where in the vasculature it is taking place; however, the
physiologic outcome may be different because of shear-
rate-dependent volumetric dilution. Regions of high shear
may be less prone to fibrin clot formation than those of
low shear because of the decreased time a given volume
of reactant fluid spends in the catalytically active region.
This correspondence has been classically suggested by
Virchow (44), as well as more recently in empirical work
by Neeves et al. (2). Observations of pathological differ-
ences between venous and arterial clots also support this
conclusion (43). Low-shear venous, red clots predominantly
consist of a fibrin network, whereas high-shear arterial,
white clots consist primarily of platelets stabilized by fibrin.
These differences are presumably due to the rates at which
the fibrin networks are formed—in venous thrombosis lower
shear rates allow for the accumulation of red blood cells
within the clot.
The Michaelis-Menten analysis of the plateau levels of
aIIaþmIIa generation at a shear rate of 250 s1 is in good
agreement with closed system experiments conducted with
the same reagents. Given the steady-state conditions for
which measurements under flow were obtained, it can be
assumed that equilibrium conditions between FII and the
membrane have been achieved and are therefore not
included in our theoretical model. Additionally, FII activa-
tion by prothrombinase is a complex process, in which
a catalytically active intermediate is treated as a product
with regard to initial rate determination. Our theoretical
model mirrors this well-established practice and utilizes
a one-step process for total aIIaþmIIa generation (14,25)
as reflected in the Michaelis-Menten constants. Correspon-
dence between our model and empirical measurements
confirms that observations made at 250 s1 can be extrapo-
lated to other physiologically relevant shear rates.
Our modeling confirms that while diffusion within the
wall region is important, there is little diffusion away for
the wall of aIIaþmIIa on the timescale of these reactions
(Fig. 3). This supports a model in which dilution is the major
physical force governing the dynamics of these reactions.
During thrombosis, aIIaþmIIa can only exist in a relativelyBiophysical Journal 100(3) 765–773
772 Haynes et al.small region close to the vessel walls, a hypothesis that has
been previously put forth in numerical modeling studies of
coagulation under flow (10) and is supported by our compu-
tational model—especially at increasing shear rates. This
reduced volume element leads to increased localized
concentrations of species where the reactive catalysts are
bound to the surface of the vasculature. It can be surmised
that concentrations of active clotting factors measured in
whole samples do not accurately represent those in the
actual region of physiologic clot formation, which can be
an order-of-magnitude higher than those observed in the
bulk solution; thus, the ability of aIIaþmIIa to drive
numerous localized reactions is greatly increased due to
flow dynamics and needs to be considered in both hemo-
static and thrombotic pathologies.
In this work, the formation of functionally compromised
des F1 species confirms the model predictions of spatially
constrained surface-derived products under flow. Although
AT is present under normal physiologic conditions and
will suppress the levels of aIIaþmIIa, we propose that the
formation of des F1 species may be a physiologically impor-
tant process because the second-order rate constants for AT
inhibition of aIIaþmIIa and des F1 species formation by
aIIaþmIIa are of the same order of magnitude (47,48).
The formation of des F1 species will lead to a negative feed-
back system for shutting down the coagulation process and
preventing further thrombus formation downstream of the
original injury site. While we do not model the formation
of des F1 species (observed to be ~3% of initial FII concen-
tration) directly, these concentrations are not surprising
given the given the high localized concentrations of
aIIaþmIIa observed in our model combined with the long
residence time of fluid in the wall region under laminar flow.
A unique aspect of studying prothrombinase under flow is
that it permits the detection of both aIIa and mIIa because
a fraction of the intermediate mIIa is removed from the
capillary and prevented from fully reacting. The observed
ratio of mIIa/aIIa is similar to that previously reported
(6). The presence of the large proportion of mIIa in the reac-
tion effluent is consistent with closed system evidence that
the reaction proceeds via a two-step mechanism in which
the zymogen FII is first converted, by cleavage at Arg323,
to the active intermediate mIIa before being released from
a first prothrombinase encounter site to seek out a second
catalytic site where it is fully converted to aIIa (14).
The failure to convert all of the reacting FII to aIIa that
was observed under flow effectively alters the procoagulant
properties of this system. mIIa has been previously identi-
fied as an intermediate of FII activation in whole blood
(49), and although it exhibits similar enzymatic activity as
aIIa toward small molecule substrates, there are several
important differences in substrate preference with physio-
logic significance. mIIa has greatly reduced activity toward
platelets and fibrinogen relative to aIIa, and thus is
comprised in its procoagulant function.Biophysical Journal 100(3) 765–773In addition, when the two thrombin species are compared
in complex with thrombomodulin (TM), the mIIa-TM
complex is relatively inefficient in activating thrombin-acti-
vatable fibrinolysis inhibitor which functions to help stabi-
lize the fibrin clot, while the mIIa-TM complex maintains
its ability to activate protein C leading to the inactivation
of FVa (34,36). Thus, aIIa serves primarily a procoagulant
function, while mIIa serves an anticoagulant function
(Table 2). The large proportion of mIIa predicted by this
model can be swept downstream of the catalytic region
where it may serve to minimize thrombus formation in addi-
tion to the accumulation of poorly reactive des F1 species.SUPPORTING MATERIAL
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